A brain chemical called neuropeptide Y (NPY), when sprayed into the nose, reduced sugar cravings and overall food intake within 3 hours in overweight mice, according to a 2026 animal study. The effect appeared specific to mice on high-fat diets and worked through a receptor called NPY2R. While promising, these findings are from animal research and human studies are needed before any treatment could be developed.
Researchers discovered that a brain chemical called neuropeptide Y (NPY) may help reduce the desire to eat sugary foods and control overall food intake. In a study with mice on high-fat diets, scientists sprayed NPY directly into the nose and found it decreased sugar cravings and food consumption within 3 hours. The treatment also increased a stress hormone called corticosterone. According to Gram Research analysis, this finding suggests NPY could become a new treatment approach for obesity and overeating, though human studies are still needed to confirm these results.
Key Statistics
A 2026 animal study published in Neurotherapeutics found that intranasal neuropeptide Y reduced sucrose preference and food intake within 3 hours specifically in mice fed a high-fat diet, with effects mediated through the NPY2R receptor.
Researchers discovered that high-fat diet feeding for 8 weeks reduced neuropeptide Y levels in mouse brains by an unspecified amount, while intranasal NPY treatment increased circulating corticosterone levels in overweight mice within 3 hours.
In mice lacking the NPY2R receptor, intranasal neuropeptide Y had no effect on sugar intake, food consumption, or corticosterone levels, confirming that NPY2R is essential for the treatment’s appetite-suppressing effects.
The Quick Take
- What they studied: Whether a brain chemical called neuropeptide Y (NPY), delivered through the nose, could reduce food cravings and overeating in mice that were overweight from eating high-fat foods.
- Who participated: Male laboratory mice divided into groups: some ate regular food and some ate a high-fat diet for 8 weeks. Different groups received either NPY or a placebo spray in their nose.
- Key finding: When NPY was sprayed into the nose of overweight mice, it reduced their desire to eat sugar and decreased overall food intake within 3 hours. This effect only worked in the overweight mice, not the normal-weight ones.
- What it means for you: This research suggests NPY could potentially become a new treatment to help people control cravings for sugary and fatty foods. However, this was only tested in mice, so much more research is needed before any human treatments could be developed.
The Research Details
Scientists used laboratory mice to test whether a brain chemical called neuropeptide Y could reduce overeating and sugar cravings. They first fed some mice a high-fat diet for 8 weeks to make them overweight, while other mice ate normal food. Then they tested how these mice behaved using simple tests: they measured how much sugar the mice wanted to eat, how much regular food they consumed, and how anxious they seemed. In a second experiment, they sprayed either NPY or a fake treatment into the mice’s noses and measured the same behaviors at different time points: 3 hours, 24 hours, and 48 hours after treatment. They also collected blood and brain samples to measure hormones and other chemicals. Finally, they tested NPY in special mice that couldn’t produce a specific NPY receptor (a protein that receives NPY’s signals) to understand how NPY was working.
This research approach is important because it helps scientists understand how brain chemicals control eating behavior and cravings. By using mice with and without specific receptors, researchers can figure out exactly which brain pathways are responsible for the effects. Testing at different time points shows how long the effects last. This careful approach gives confidence that any effects are real and not just random.
This study was published in a peer-reviewed scientific journal, meaning other experts reviewed the work before publication. The researchers used multiple testing methods to measure eating behavior and tested their findings in mice lacking specific receptors to confirm their theory. However, this is animal research, so results may not directly apply to humans. The study did not specify the exact number of mice used, which would help readers understand the study’s power.
What the Results Show
When mice ate a high-fat diet for 8 weeks, they showed less interest in eating sugar compared to normal-weight mice. Interestingly, this change in sugar preference happened without making the mice more anxious. The researchers also found that overweight mice had lower levels of NPY in their brains and lower levels of a stress hormone called corticosterone in their blood. When scientists sprayed NPY into the noses of overweight mice, something interesting happened: within 3 hours, the mice ate less sugar and showed less preference for sugar compared to mice that received a fake spray. This effect was specific to the overweight mice and did not occur in normal-weight mice. The NPY treatment also increased corticosterone levels in the overweight mice’s blood. However, when the same NPY spray was given 24 or 48 hours later, these effects on sugar preference disappeared, suggesting the treatment’s effects were temporary.
NPY reduced overall food intake in both normal-weight and overweight mice within 3 hours, showing a broader appetite-suppressing effect beyond just sugar cravings. When researchers tested NPY in special mice that lacked a specific NPY receptor called NPY2R, the treatment no longer worked: it didn’t reduce sugar intake, didn’t change food preferences, didn’t reduce overall eating, and didn’t increase corticosterone. This finding strongly suggests that NPY works specifically through the NPY2R receptor. The study found no significant changes in inflammation markers in the blood or brain, suggesting that inflammation may not be the main mechanism behind NPY’s effects.
Previous research has shown that NPY is involved in controlling hunger and eating behavior, but most studies focused on injecting NPY directly into the brain. This study is novel because it used intranasal delivery, meaning the NPY was sprayed into the nose rather than injected into the brain. This approach is less invasive and more practical for potential human treatments. The finding that NPY affects reward-driven eating (sugar preference) rather than just basic hunger is a new contribution to our understanding of how this brain chemical works. The connection between NPY, stress hormones, and eating behavior adds to growing evidence that emotional and metabolic systems are closely linked.
This research was conducted only in mice, so the results may not directly apply to humans. The study did not report the exact number of mice used in each experiment, making it harder to assess the statistical power. The treatment only worked within a 3-hour window, and effects disappeared by 24 hours, raising questions about practical usefulness. The study only tested male mice, so it’s unclear whether the results would be the same in female mice. The researchers did not test whether repeated NPY treatments would continue to work or if mice would develop tolerance. Finally, this study doesn’t explain exactly why NPY works differently in overweight versus normal-weight mice, which limits our understanding of the mechanism.
The Bottom Line
Based on this research, NPY delivered through the nose shows promise as a potential treatment for reducing sugar cravings and overeating in people with obesity. However, these findings are from animal studies only. Before anyone should consider NPY as a treatment, human clinical trials are needed to confirm safety and effectiveness. Current evidence suggests moderate confidence in the mechanism but low confidence in real-world human application. People interested in managing cravings should continue using proven strategies like dietary changes, exercise, and behavioral therapy while this research continues.
This research is most relevant to people struggling with obesity, sugar cravings, and overeating, as well as researchers developing new obesity treatments. It may also interest people with eating disorders or those studying the connection between stress, emotions, and eating. People with normal weight and healthy eating habits may find this less immediately relevant. Healthcare providers treating obesity should monitor this research but should not yet recommend NPY-based treatments outside of clinical trials.
In this mouse study, NPY’s effects on sugar preference appeared within 3 hours but disappeared by 24 hours, suggesting any human treatment would need frequent dosing. If human trials begin, it typically takes 5 to 10 years to move from animal studies to approved medications. Realistic expectations are that NPY-based treatments, if proven safe and effective in humans, would not be available for several years at minimum.
Frequently Asked Questions
Can neuropeptide Y help me stop craving sugar and junk food?
Research shows NPY reduced sugar cravings in overweight mice within 3 hours when sprayed into the nose. However, this was only tested in animals. Human studies are needed before NPY could become a real treatment for food cravings.
How does neuropeptide Y reduce appetite and food cravings?
NPY works through a brain receptor called NPY2R to suppress eating, particularly for sugary foods. The 2026 study found that mice without this receptor didn’t respond to NPY treatment, proving NPY2R is essential for the effect.
Is neuropeptide Y treatment available for weight loss now?
No. This research is preliminary and only tested in mice. Intranasal NPY is not an approved human treatment. Typical development takes 5 to 10 years from animal studies to human medications, so availability is years away.
Why does obesity change how the brain’s appetite chemicals work?
The study found that mice on high-fat diets had lower neuropeptide Y levels in their brains and lower stress hormone levels. This suggests obesity alters the brain’s natural appetite control system, making it harder to regulate eating.
Does neuropeptide Y treatment work the same in everyone?
This study only tested male mice, so it’s unclear whether NPY would work the same in females. The treatment only worked in overweight mice, not normal-weight ones, suggesting body composition matters for effectiveness.
Want to Apply This Research?
- Track daily sugar cravings on a scale of 1 to 10 and log actual sugar intake in grams. Record mood and stress levels alongside cravings to identify patterns between emotional state and eating urges.
- Users could set daily goals to reduce sugar intake by 10 percent and use the app to log each time they successfully resist a sugar craving. The app could send reminders about stress-management techniques when cravings spike, since this research links stress hormones to eating behavior.
- Over 4 weeks, track whether cravings decrease as users implement stress-reduction techniques like exercise or meditation. Compare weeks when stress is high versus low to see the connection between emotional state and food preferences, mirroring the research’s findings about stress hormones and eating.
This research was conducted in laboratory mice and has not been tested in humans. Neuropeptide Y is not an approved treatment for obesity or food cravings in any country. Anyone struggling with overeating, obesity, or disordered eating should consult with a healthcare provider or registered dietitian for evidence-based treatment options. Do not attempt to self-treat with any experimental compounds. This article is for educational purposes only and should not be considered medical advice.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.